Drug intelligence / Profile preview

Voclosporin ophthalmic solution

Development stage
Unknown
Lead developer
Aurinia
Modality
Small Molecules
Administration
Topical, Ophthalmic
01

Overview

Voclosporin ophthalmic solution (VOS) is a proprietary nanomicellar formulation of voclosporin designed for topical ophthalmic use. This clear, aqueous, and preservative-free solution allows for high concentrations of voclosporin to be delivered locally to the ocular surface. The nanomicellar technology aims to improve the delivery of the active drug to target tissues, potentially offering benefits in efficacy, dosing frequency, and tolerability compared to existing dry eye treatments like Restasis®. Voclosporin is a calcineurin inhibitor immunosuppressant. Its mechanism involves decreasing immune system activity by blocking IL-2 expression and T-cell mediated immune responses, which helps reduce inflammation when applied ophthalmically.

Other names
Voclosporin nanomicellar ophthalmic solution
02

Targets

CN (Calcineurin)

Beyond the preview

Go deeper on Voclosporin ophthalmic solution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voclosporin ophthalmic solution.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call